Oculis Holding AG (OCS) Cash from Operations (2022 - 2026)

Oculis Holding AG's (OCS) quarterly Cash from Operations came in at 19585420.81 in Q1 2026, up 7.14% year-on-year from 18280015.07 in Q1 2025, and up 6.16% quarter-over-quarter from 20870763.3 in Q4 2025.

Oculis Holding AG (OCS) Cash from Operations (2022 - 2026) Analysis & Trends

Oculis Holding AG's Cash from Operations history runs 5 years deep, the most recent figure standing at 19585420.81 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 7.14% year-over-year to 19585420.81 in Q1 2026; TTM through Mar 2026 was 78056596.89, a 28.13% decrease from a year earlier, with the FY2025 full-year figure at 79971143.7, down 43.82% from the prior year.
  • Cash from Operations grew to 19585420.81 in Q1 2026 per OCS's latest filing, from 20870763.3 in the prior quarter.
  • Across five years, Cash from Operations topped out at 6781397.15 in Q4 2022 and bottomed at 21091606.91 in Q1 2025.
  • The 5-year median for Cash from Operations is 15718761.35 (2024), against an average of 15322007.63.
  • Across the five-year window, Cash from Operations sank 136.21% in 2023 and grew 24.15% in 2024, its largest moves.
  • Year by year, Cash from Operations stood at 6781397.15 in 2022, then sank by 136.21% to 16018579.72 in 2023, then advanced by 24.15% to 12150358.55 in 2024, then plunged by 71.77% to 20870763.3 in 2025, then increased by 6.16% to 19585420.81 in 2026.
  • Per Business Quant, the three latest OCS Cash from Operations figures stand at 19585420.81 (Q1 2026), 20870763.3 (Q4 2025), and 16773969.47 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -19.59 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 201.34 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.53 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.43 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.08 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -354.17 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 70.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.59 Mn
Mar 31, 2026 -19.59 Mn
Dec 31, 2025 -20.87 Mn
Dec 31, 2025 -20.87 Mn
Sep 30, 2025 -16.77 Mn
Sep 30, 2025 -16.77 Mn
Jun 30, 2025 -20.83 Mn
Jun 30, 2025 -20.83 Mn
Mar 31, 2025 -21.09 Mn
Mar 31, 2025 -21.09 Mn
Dec 31, 2024 -12.15 Mn
Dec 31, 2024 -12.15 Mn
Sep 30, 2024 -12.48 Mn
Sep 30, 2024 -12.48 Mn
Jun 30, 2024 -15.19 Mn
Jun 30, 2024 -15.19 Mn
Mar 31, 2024 -15.72 Mn
Mar 31, 2024 -15.72 Mn
Dec 31, 2023 -16.02 Mn
Dec 31, 2023 -16.02 Mn